Cano Health (NYSE:CANO) Stock Rating Lowered by UBS Group
Cano Health (NYSE:CANO) Stock Rating Lowered by UBS Group
UBS Group lowered shares of Cano Health (NYSE:CANO – Get Rating) from a buy rating to a neutral rating in a research note released on Friday morning, MarketBeat reports. They currently have $1.25 target price on the stock, down from their previous target price of $12.00.
瑞银集团下调了的股票 Cano Health（纽约证券交易所：CANO — 获取评级） MarketBeat报告称，在周五上午发布的研究报告中，从买入评级到中性评级。他们目前的股票目标价格为1.25美元，低于之前的12.00美元的目标价格。
Several other equities research analysts have also issued reports on CANO. Cowen lowered shares of Cano Health from an outperform rating to a market perform rating and lowered their price target for the company from $10.00 to $3.00 in a report on Thursday, November 10th. Raymond James downgraded shares of Cano Health from an outperform rating to a market perform rating in a research note on Thursday, November 10th. Wolfe Research downgraded shares of Cano Health from an outperform rating to a peer perform rating in a research note on Thursday, January 5th. Credit Suisse Group reduced their target price on shares of Cano Health to $4.00 in a research note on Monday, November 28th. Finally, Cowen downgraded shares of Cano Health from an outperform rating to a market perform rating and reduced their target price for the company from $10.00 to $3.00 in a research note on Thursday, November 10th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of Hold and an average target price of $4.08.
其他几位股票研究分析师也发布了有关CANO的报告。在11月10日星期四的一份报告中，Cowen将Cano Health的股票评级从跑赢大盘下调至市场表现评级，并将该公司的目标股价从10.00美元下调至3.00美元。雷蒙德·詹姆斯在11月10日星期四的一份研究报告中将Cano Health的股票评级从跑赢大盘下调至市场表现评级。Wolfe Research在1月5日星期四的一份研究报告中将Cano Health的股票评级从跑赢大盘下调至同行表现评级。瑞士信贷集团在11月28日星期一的一份研究报告中将Cano Health股票的目标价格下调至4.00美元。最后，Cowen在11月10日星期四的一份研究报告中将Cano Health的股票评级从跑赢大盘下调至市场表现评级，并将该公司的目标价格从10.00美元下调至3.00美元。两位研究分析师对该股进行了卖出评级，七位给出了持有评级，一位对该股发布了买入评级。根据Marketbeat.com的数据，该公司目前的平均评级为持有，平均目标价为4.08美元。
Cano Health Trading Up 13.2 %
Cano Health 交易上涨了 13.2%
Shares of Cano Health stock opened at $1.20 on Friday. The firm has a market capitalization of $593.38 million, a PE ratio of -3.16 and a beta of 0.15. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.64 and a quick ratio of 1.64. The company's fifty day moving average price is $1.83 and its two-hundred day moving average price is $4.66. Cano Health has a 52-week low of $0.98 and a 52-week high of $9.75.
周五，Cano Health股票开盘价为1.20美元。该公司的市值为5.9338亿美元，市盈率为-3.16，beta值为0.15。该公司的债务与权益比率为1.17，流动比率为1.64，速动比率为1.64。该公司的五十天移动平均价格为1.83美元，其两百天移动平均线价格为4.66美元。Cano Health创下52周低点0.98美元，52周高点为9.75美元。
Institutional Inflows and Outflows
机构流入和流出
Several institutional investors and hedge funds have recently added to or reduced their stakes in CANO. Raymond James & Associates lifted its position in Cano Health by 12.1% during the 1st quarter. Raymond James & Associates now owns 125,611 shares of the company's stock worth $798,000 after buying an additional 13,593 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its position in Cano Health by 18.6% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 169,145 shares of the company's stock valued at $1,074,000 after purchasing an additional 26,550 shares during the period. Bank of New York Mellon Corp lifted its position in Cano Health by 19.2% during the 1st quarter. Bank of New York Mellon Corp now owns 78,241 shares of the company's stock valued at $497,000 after purchasing an additional 12,578 shares during the period. HighTower Advisors LLC acquired a new position in Cano Health during the 1st quarter valued at about $129,000. Finally, Allianz Asset Management GmbH acquired a new position in Cano Health during the 1st quarter valued at about $2,268,000. Institutional investors and hedge funds own 25.56% of the company's stock.
一些机构投资者和对冲基金最近增加了或减少了在CANO的股份。Raymond James & Associates在第一季度将其在Cano Health的职位提高了12.1％。Raymond James & Associates在上个季度又购买了13,593股股票后，现在拥有该公司125,611股股票，价值79.8万美元。雷蒙德·詹姆斯金融服务顾问公司在第一季度将其在Cano Health的头寸提高了18.6％。雷蒙德·詹姆斯金融服务顾问公司在此期间又购买了26,550股股票后，现在拥有该公司169,145股股票，价值1,074,000美元。纽约银行梅隆公司在第一季度将其在Cano Health的头寸提高了19.2％。纽约银行梅隆公司在此期间又购买了12,578股股票后，现在拥有该公司78,241股股票，价值49.7万美元。HighTower Advisors LLC在第一季度收购了Cano Health的新职位，价值约12.9万美元。最后，安联资产管理有限公司在第一季度收购了Cano Health的新职位，价值约226.8万美元。机构投资者和对冲基金拥有该公司25.56％的股票。
Cano Health Company Profile
Cano Health 公司简介
(Get Rating)
（获取评分）
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
Cano Health, Inc为其在美国和波多黎各的成员提供初级保健医疗服务。它拥有并运营由Canopanorama支持的医疗中心，Canopanorama是一个由人口健康管理技术支持的专有平台，可为其医疗中心的医疗保健提供者提供其成员的360度全方位视图，并提供切实可行的见解，从而改善护理决策和成员参与度。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- 3 Airline Stocks Taking Off in 2023
- Why Wall Street Has Bullish Targets on Target Stock
- What Macy's Guidance Means For Retail
- Fortinet Stock Price Bumpy, Here Is Why
- Apexigen Stock Soars After Analyst Rating, Is It Time to Buy?
- 免费获取 StockNews.com 关于 Cano Health (CANO) 的研究报告
- 3 只航空股将在 2023 年上涨
- 为什么华尔街对目标股票设定看涨目标
- 梅西百货的指导对零售意味着什么
- Fortinet 股价颠簸，这就是原因
- 分析师评级后，Apexigen股票飙升，是时候买入了吗？
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Cano Health Daily 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Cano Health及相关公司的最新新闻和分析师评级的简明每日摘要。